Pharma Mar (OTCMKTS:PHMMF) Hits New 52-Week High – What’s Next?

Pharma Mar, S.A. (OTCMKTS:PHMMF) reached a new 52-week high during mid-day trading on Thursday . The company traded as high as $75.00 and last traded at $75.00, with a volume of 0 shares. The stock had previously closed at $75.00.

Wall Street Analysts Forecast Growth

Separately, Chardan Capital upgraded Pharma Mar to a “strong-buy” rating in a research note on Thursday, August 1st.

Pharma Mar Price Performance

The company has a current ratio of 2.55, a quick ratio of 2.01 and a debt-to-equity ratio of 0.14. The company’s fifty day moving average is $60.64 and its 200-day moving average is $42.84.

About Pharma Mar

Pharma Mar, SA, a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally. The company operates through Oncology and RNA Interference segments.